ZA984635B - Orally active iron (III) chelators. - Google Patents

Orally active iron (III) chelators.

Info

Publication number
ZA984635B
ZA984635B ZA9804635A ZA984635A ZA984635B ZA 984635 B ZA984635 B ZA 984635B ZA 9804635 A ZA9804635 A ZA 9804635A ZA 984635 A ZA984635 A ZA 984635A ZA 984635 B ZA984635 B ZA 984635B
Authority
ZA
South Africa
Prior art keywords
hydrogen
aryl
group
aralkyl
alkyl
Prior art date
Application number
ZA9804635A
Other languages
English (en)
Inventor
Robert Charles Hider
Gary Stuart Tilbrook
Zudong Liu
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of ZA984635B publication Critical patent/ZA984635B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9804635A 1997-05-29 1998-05-29 Orally active iron (III) chelators. ZA984635B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9711093.6A GB9711093D0 (en) 1997-05-29 1997-05-29 Novel orally active iron (III) chelators

Publications (1)

Publication Number Publication Date
ZA984635B true ZA984635B (en) 1999-11-29

Family

ID=10813233

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9804635A ZA984635B (en) 1997-05-29 1998-05-29 Orally active iron (III) chelators.

Country Status (12)

Country Link
US (2) US6335353B1 (xx)
EP (1) EP0984934B1 (xx)
JP (1) JP2002500663A (xx)
AT (1) ATE230728T1 (xx)
AU (1) AU751600B2 (xx)
CA (1) CA2287907C (xx)
DE (1) DE69810619T2 (xx)
DK (1) DK0984934T3 (xx)
ES (1) ES2187025T3 (xx)
GB (1) GB9711093D0 (xx)
WO (1) WO1998054138A1 (xx)
ZA (1) ZA984635B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1220870B1 (en) 1999-10-01 2012-04-11 DMI Biosciences, Inc. Metal-binding compounds and uses therefor
US6426418B1 (en) 2001-11-02 2002-07-30 Apotex, Inc. Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
WO2003065991A2 (en) 2002-02-05 2003-08-14 Bristol-Myers Squibb Company N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
US8058442B2 (en) 2002-11-07 2011-11-15 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
NZ529657A (en) * 2003-11-20 2004-07-30 Apotex Inc Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones
CA2488034C (en) * 2004-11-19 2009-10-06 Apotex Inc. Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
GB0506677D0 (en) * 2005-04-01 2005-05-11 Btg Int Ltd Iron modulators
TWI404533B (zh) * 2007-03-28 2013-08-11 Apotex Technologies Inc 去鐵酮（ｄｅｆｅｒｉｐｒｏｎｅ）之氟化衍生物
GB0803019D0 (en) * 2008-02-19 2008-03-26 Btg Int Ltd Fluorinated compounds
UA102254C2 (ru) 2008-04-25 2013-06-25 Апотекс Технолоджис Инк. Жидкий состав для деферипрона с приятным вкусом
KR101695807B1 (ko) 2008-07-25 2017-01-13 비이브 헬쓰케어 컴퍼니 화합물
ES2964383T3 (es) 2008-12-11 2024-04-05 Viiv Healthcare Co Procesos e intermedios para inhibidores de la integrasa del VIH de carbamoilpiridona
MX2011006241A (es) 2008-12-11 2011-06-28 Shionogi & Co Sintesis de inhibidores de integrasa de vih de carbamoil-piridona e intermediarios.
TWI518084B (zh) 2009-03-26 2016-01-21 鹽野義製藥股份有限公司 哌喃酮與吡啶酮衍生物之製造方法
CN102712591B (zh) 2009-07-03 2014-06-25 阿普泰克斯科技公司 3-羟基吡啶-4-酮的氟化衍生物
TWI582097B (zh) 2010-03-23 2017-05-11 Ｖｉｉｖ醫療保健公司 製備胺甲醯吡啶酮衍生物及中間體之方法
CN109438405B (zh) * 2018-12-24 2023-04-07 广东莱佛士制药技术有限公司 一种3-(苄氧基)-4-氧代-4h-吡喃-2-羧酸的合成方法
WO2020132820A1 (zh) * 2018-12-24 2020-07-02 广东莱佛士制药技术有限公司 一种3-(苄氧基)-4-氧代-4h-吡喃-2-羧酸的合成方法
CN111606879A (zh) * 2020-05-25 2020-09-01 安徽金禾实业股份有限公司 一锅法制备2-羟甲基-3-烷氧基-4h-吡喃-4-酮的方法
CN113121423B (zh) * 2021-03-10 2022-07-22 浙江工业大学 Ala杂合3-羟基吡啶酮衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518098A1 (de) * 1963-09-19 1969-04-10 Pfizer & Co C Verfahren zur Herstellung von Pyromekonsaeurederivaten
US3468915A (en) * 1966-04-18 1969-09-23 Pfizer & Co C Novel 2-substituted-6-methylpyromeconic acids
JPS5921954B2 (ja) * 1980-02-13 1984-05-23 新日本製鐵株式会社 鋼材の防錆処理方法
US5112968A (en) * 1989-07-28 1992-05-12 E. R. Squibb & Sons, Inc. Monobactam hydrazide derivatives
GB9006522D0 (en) * 1990-03-23 1990-05-23 Hider Robert C Metal complexes
DE59611243D1 (de) * 1995-09-29 2005-08-11 Novartis Ag Hydroxypyridinone

Also Published As

Publication number Publication date
US6506911B2 (en) 2003-01-14
US20020068758A1 (en) 2002-06-06
CA2287907A1 (en) 1998-12-03
DE69810619D1 (de) 2003-02-13
DE69810619T2 (de) 2003-09-25
US6335353B1 (en) 2002-01-01
EP0984934A1 (en) 2000-03-15
DK0984934T3 (da) 2003-05-05
CA2287907C (en) 2009-01-13
ATE230728T1 (de) 2003-01-15
EP0984934B1 (en) 2003-01-08
AU751600B2 (en) 2002-08-22
AU7542798A (en) 1998-12-30
JP2002500663A (ja) 2002-01-08
GB9711093D0 (en) 1997-07-23
ES2187025T3 (es) 2003-05-16
WO1998054138A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
GB9711093D0 (en) Novel orally active iron (III) chelators
NZ332363A (en) substituted 4-hydroxy-isoquinoline-3carboxamide derivatives and medicaments
ES8103734A1 (es) Procedimiento para preparar nuevos derivados de piperidina
TW350771B (en) Heteroacetic acid derivatives
ES8405364A1 (es) Metodo de preparar amidoaminoacidos n-substituidos.
UA39869C2 (uk) Похідні аспартаму або їх фізіологічно прийнятні солі, спосіб їх отримання та підсолоджувальна композиція
DE3275295D1 (en) Anti-srs-a carboxylic acid derivatives, processes for their production, and pharmaceutical formulation containing them
HK1055726A1 (en) Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
CA2304713A1 (en) Biphenyl-5-alkanoic acid derivatives and use thereof
JPS5681561A (en) Anilide derivative* its manufacture and its use
GR3031517T3 (en) RARy-specific retinobenzoic acid derivatives
ES8605506A1 (es) Procedimiento para preparar derivados de piperidina
ATE28187T1 (de) Polyprenylcarbonsaeureamide und verfahren zu ihrer herstellung.
BG104445A (en) NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
ES8607218A1 (es) Un procedimiento para preparar compuestos de amidina
ZA816259B (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
KR950702529A (ko) 신규한 비타민 D 동족체(Novel vitamin D analogues)
ES457001A1 (es) Un procedimiento de preparacion de derivados de fenetilamina.
ES459186A1 (es) Un procedimiento para la preparacion de un compuesto de aci-do poliprenilcarboxilico.
IE792300L (en) 2,4, 6-triiodoisophthalamic acid derivatives; x-ray¹contrast agents
ES8301895A1 (es) "procedimiento para preparar nuevos acidos 2-amino-3-(halobenzoil)-metilfenilaceticos,sus esteres y sus sales metalicas".
IL67023A (en) Substituted thiazolidinyl esters of phosphoric and sulfuric acid
UA41340C2 (uk) Похідні циклогексанкарбонової кислоти, суміш їх ізомерів або окремі ізомери і фізіологічно прийнятні солі і фармацевтична композиція з активністю, що гальмує ферментний комплекс глюкоза-6-фосфатази
ES8205219A1 (es) Un metodo para producir un compuesto de hidrouracilo
ES8704081A1 (es) Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-piridil-n-furilmetilpropilaminas